Abstract
Objective
Characterize severity of opioid use disorder during pregnancy over time.
Study design
A retrospective chart review of pregnant women presenting to MetroHealth’s Mother and Child Dependency program from 2002–2019 was performed. Severity of opioid use disorder was assessed by multinomial multivariable logistic regression of five discrete measures. Term birth rates and MAT use were analyzed using univariate regression.
Results
606 women were included in this study. Duration of use, age at first use, polysubstance use, and route of administration did not significantly change over time. Significantly more women reported high use (>1 g daily) over time compared to low use (<0.5 g daily) (RRR = 1.21, p < 0.01). Buprenorphine use increased compared to methadone use (RRR = 1.54, p < 0.001). Rate of full-term delivery increased (RRR = 1.14, p < 0.001).
Conclusions
Severity of opioid use disorder during pregnancy did not change over time. An increase in term births and preference for buprenorphine were observed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, et al. Trends in opioid analgesic abuse and mortality in the United States. N. Engl J Med. 2015;372:241–8.
Hedegaard H, Drug overdose deaths in the United States, 1999–2017. National Center For Health Statistics. 2018. https://www.cdc.gov/nchs/products/databriefs/db329.htm.
Haight SC, Opioid Use Disorder Documented at Delivery Hospitalization—United States, 1999–2014. MMWR Morb Mortal Wkly. Rep. 2018;67:845–9.
Opioid use and opioid use disorder in pregnancy. American College of Obstetricians and Gynecologists. (2017). https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy
Stam NC, Gerostamoulos D, Gerstner-Stevens J, Scott N, Smith K, Drummer OH, et al. Determining the effective dose of street-level heroin: a new way to consider fluctuations in heroin purity, mass and potential contribution to overdose. Forensic Sci Int. 2018;290:219–26.
Gilson TP, Heroin/Fentanyl/Cocaine related deaths in Cuyahoga County. Cuyahoga County Medical Examiner’s Office (2020). http://medicalexaminer.cuyahogacounty.us/pdf_medicalexaminer/en-US/HeroinFentanylReports/011920-HeroinFentanylReport.pdf
Pinto S, Dodd S, Walkinshaw S, Siney C, Kakkar P, Mousa H. Substance abuse during pregnancy: effect on pregnancy outcomes. EJOG. 2010;150:137–41.
Creanga AA, Sabel JC, Ko JY, Wasserman CR, Shapiro-Mendoza CK, Taylor P, et al. Maternal drug use and its effect on neonates: a population-based study in Washington State. Obstet Gynecol. 2012;119:924–33.
Low birth weight and preterm birth. Ohio Department of Health. (2014). https://odh.ohio.gov/wps/wcm/connect/gov/e4fdb2fe-8ed5-4aed-a0e7-030471fff411/Low-Birth-Weight-2014.pdf?MOD=AJPERES&CONVERT_TO=url&CACHEID=ROOTWORKSPACE.Z18_M1HGGIK0N0JO00QO9DDDDM3000-e4fdb2fe-8ed5-4aed-a0e7-030471fff411-mqycGfX
Johnson T, Conrey EJ, Oza-Frank R, Arendt A, Mattson B, Montgomery M, Extremely premature births in Ohio, 2017. Ohio Department of Health (2018). https://odh.ohio.gov/wps/wcm/connect/gov/0315225f-0275-49b4-9fbf-5ec98e3ac590/Extremely+Premature+Births+in+Ohio+2017-+report.pdf?MOD=AJPERES&CONVERT_TO=url&CACHEID=ROOTWORKSPACE.Z18_M1HGGIK0N0JO00QO9DDDDM3000-0315225f-0275-49b4-9fbf-5ec98e3ac590-mLmEjsu
Binder T, Vavrinková B. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome in women followed up in the outpatient department. Neuro Endocrinol Lett. 2008;29:80–86.
Zedler BK, Mann AL, Kim MM, Amick HR, Joyce AR, Murrelle EL, et al. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child. Addiction 2016;111:2115–28.
Chen CY, Wang IA, Fang SY, Huang N, Tsay JH, Chang SH. Inadequate prenatal care utilization among women with and without methadone-treated opioid use disorders in Taiwan. Int J Drug Policy. 2019;67:1–8.
Author information
Authors and Affiliations
Contributions
SS: Conceptualization, Methodology, Investigation, Data curation, Formal analysis, Writing–Original draft, Visualization. GBS: Conceptualization, Methodology, Investigation, Data curation, Formal analysis, Writing–Original draft, Visualization. JLB: Writing–Review & Editing, Supervision, Project administration.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sundaresh, S., Sadananda, G.B. & Bailit, J.L. Trends in the severity of opioid use disorder during pregnancy over time. J Perinatol 42, 1032–1037 (2022). https://doi.org/10.1038/s41372-022-01336-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-022-01336-2